Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Corbus Pharmaceuticals Holding

CRBP
Current price
50.04 USD -0.35 USD (-0.69%)
Last closed 50.77 USD
ISIN US21833P1030
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 736 845 824 USD
Yield for 12 month +608.78 %
1Y
3Y
5Y
10Y
15Y
CRBP
21.11.2021 - 28.11.2021

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts. Address: 500 River Ridge Drive, Norwood, MA, United States, 02062

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

81.43 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-641 000 USD

Last Year

-1 487 853 USD

Current Quarter

-200 000 USD

Last Quarter

-151 688 USD

Key Figures CRBP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -39 599 700 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -25.68 %
PEG Ratio
Return On Equity TTM -51.78 %
Wall Street Target Price 81.43 USD
Revenue TTM
Book Value 10.92 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM -16 136 826 USD
Earnings per share -5.79 USD
Diluted Eps TTM -5.79 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CRBP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CRBP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:30
Payout Ratio
Last Split Date 14.02.2023
Dividend Date

Stock Valuation CRBP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 8.2564
Price Sales TTM 163.3187
Enterprise Value EBITDA 0.1697
Price Book MRQ 5.8578

Financials CRBP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CRBP

For 52 weeks

3.03 USD 61.9 USD
50 Day MA 54.2 USD
Shares Short Prior Month 1 198 096
200 Day MA 33.85 USD
Short Ratio 4.5
Shares Short 1 215 923
Short Percent 12.16 %

Dynamics of changes in the value of assets

S

SCWX

8.28 USD Secureworks Corp -0.01 (-0.12%)
Detailed analytics
3

3863

912.00 JPY Nippon Paper Industries Co. Ltd. -0.1 (-1.62%)
Detailed analytics
M

MTY

41.57 CAD MTY Food Group Inc -0.1 (-0.31%)
Detailed analytics
0

0RTR

41.58 EUR Jost Werke AG -0.33 (-0.72%)
Detailed analytics
6

603135

8.09 CNY Zhongzhong Science & Technology (Tianjin) Co. Ltd. A -0.02 (-2.06%)
Detailed analytics